Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Corona Remedies has informed that the officials of the Company will be meeting analysts / investors on Wednesday, September 23, 2026 at 2:00 pm organized by JP Morgan in Ahmedabad. Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This intimation is also being made available on the website of the Company at www.coronaremedies.com.
The above information is a part of company’s filings submitted to BSE.
